TEVA RESPIRATORY, LLC
WEST CHESTER, PA

TEVA RESPIRATORY, LLC, an influential player in the US pharmaceutical landscape, is dedicated to providing high-quality and cost-effective treatment solutions for respiratory conditions and allergy symptoms. With a focus on addressing unmet medical needs, Teva Respiratory innovates by developing novel delivery systems and therapies tailored specifically for respiratory care. The company holds a prominent position as the second-leading branded respiratory company in the US based on prescription volume. Headquartered in West Chester, Leon County, Florida, TEVA RESPIRATORY was incorporated on December 27, 2006, under the filed number L06000122176. Governed by FLAL company type regulations, it maintains its mailing address at 145 Brandywine Parkway, West Chester, PA, with active business operations detailed in Florida's official registry. The leadership team comprises Christine Fox as President and Sharon Barber-Lui serving as Senior, while Brian Shanahan fulfills the role of Vice President. The organization prioritizes patient care through its specialized product portfolio and offers direct support to medical professionals, accessible via several contact numbers including (888) 838-2872 and a dedicated reporting line for adverse events. The company's commitment is reflected in its regular filings, with the latest event on May 12, 2022, indicating changes in registered agents or officers. The forthcoming annual report due on May 1, 2024, will provide further updates on fiscal activities for the year 2024. TEVA RESPIRATORY continues to expand its reach and capabilities through a robust online presence at tevarespiratory.com.